Standard

Autoprobiotics as an Approach for Restoration of Personalised Microbiota. / Суворов, Александр Николаевич; Карасева, Алена Борисовна; Котылева, Марина Петровна; Кондратенко, Юлия Дмитриевна; Лавренова, Надежда; Коробейников, Антон Иванович; Козырев, Петр Александрович; Крамская, Татьяна Анатольевна ; Леонтьева, Галина; Кудрявцев, Игорь Владимирович; Guo, Danyang; Лапидус, Алла Львовна; Ермоленко, Елена Игоревна.

в: Frontiers in Microbiology, Том 9, № SEP, 1869, 12.09.2018.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Суворов, АН, Карасева, АБ, Котылева, МП, Кондратенко, ЮД, Лавренова, Н, Коробейников, АИ, Козырев, ПА, Крамская, ТА, Леонтьева, Г, Кудрявцев, ИВ, Guo, D, Лапидус, АЛ & Ермоленко, ЕИ 2018, 'Autoprobiotics as an Approach for Restoration of Personalised Microbiota', Frontiers in Microbiology, Том. 9, № SEP, 1869. https://doi.org/10.3389/fmicb.2018.01869

APA

Суворов, А. Н., Карасева, А. Б., Котылева, М. П., Кондратенко, Ю. Д., Лавренова, Н., Коробейников, А. И., Козырев, П. А., Крамская, Т. А., Леонтьева, Г., Кудрявцев, И. В., Guo, D., Лапидус, А. Л., & Ермоленко, Е. И. (2018). Autoprobiotics as an Approach for Restoration of Personalised Microbiota. Frontiers in Microbiology, 9(SEP), [1869]. https://doi.org/10.3389/fmicb.2018.01869

Vancouver

Суворов АН, Карасева АБ, Котылева МП, Кондратенко ЮД, Лавренова Н, Коробейников АИ и пр. Autoprobiotics as an Approach for Restoration of Personalised Microbiota. Frontiers in Microbiology. 2018 Сент. 12;9(SEP). 1869. https://doi.org/10.3389/fmicb.2018.01869

Author

Суворов, Александр Николаевич ; Карасева, Алена Борисовна ; Котылева, Марина Петровна ; Кондратенко, Юлия Дмитриевна ; Лавренова, Надежда ; Коробейников, Антон Иванович ; Козырев, Петр Александрович ; Крамская, Татьяна Анатольевна ; Леонтьева, Галина ; Кудрявцев, Игорь Владимирович ; Guo, Danyang ; Лапидус, Алла Львовна ; Ермоленко, Елена Игоревна. / Autoprobiotics as an Approach for Restoration of Personalised Microbiota. в: Frontiers in Microbiology. 2018 ; Том 9, № SEP.

BibTeX

@article{cbc98853c93449f4917cfa266963be3d,
title = "Autoprobiotics as an Approach for Restoration of Personalised Microbiota",
abstract = "Human microbiota is a complex consortium of microorganisms involved in the proper functioning of almost every system of the organism. Majority of the human diseases are associated with the development of intestinal dysbiosis. Dysbiotic condition or dysbiosis is a key pathogenic condition causing many severe infectious or non-infectious diseases. Rapid return to the original microbiota in many cases leads to the fast recovery from the disease. However, the optimal way of the treatment of dysbiosis is still under the discussion. Recently we have developed a method of autoprobiotics based on using isolated indigenous bacteria for improving of microbiota condition. The method based on feeding the patients with bacterial products grown from their personal, genetically characterised strains have been successfully tested in clinic on patients with IBS or chronic pneumonia. In present study we tried to evaluate technology employing autoprobiotic bacteria belonging to different species employing the rat model of antibiotic induced dysbiosis. Six experimental groups of animals after taking antibiotics were treated with different variants of autoprobiotics (lactobacillus, bifidobacteria, enterococcus, their mixture, fecal microbiota, or anaerobically grown complex of indigenous microbiota) prepared for each of them before the development of dysbiosis. Judging by the multiple parameters including metagenomics analysis of microbiota, immune status and microbiota content of the animals with dysbiosis relatively to control group, the most pronounced positive changes were provided by autoprobiotics based on enterococci, bifidobacteria or the consortium of indigenous bacteria grown under anaerobic conditions. These groups of autoprobiotics were delivering the most effective restoration of the original microbiota content and significant anti-inflammatory reaction of the immune system.",
keywords = "Anti-inflammatory, Autoprobiotics, Intestinal dysbiosis, Microbiome, Microbiota, microbiota, anti-inflammatory, PROBIOTICS, intestinal dysbiosis, autoprobiotics, microbiome",
author = "Суворов, {Александр Николаевич} and Карасева, {Алена Борисовна} and Котылева, {Марина Петровна} and Кондратенко, {Юлия Дмитриевна} and Надежда Лавренова and Коробейников, {Антон Иванович} and Козырев, {Петр Александрович} and Крамская, {Татьяна Анатольевна} and Галина Леонтьева and Кудрявцев, {Игорь Владимирович} and Danyang Guo and Лапидус, {Алла Львовна} and Ермоленко, {Елена Игоревна}",
year = "2018",
month = sep,
day = "12",
doi = "10.3389/fmicb.2018.01869",
language = "English",
volume = "9",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S.A.",
number = "SEP",

}

RIS

TY - JOUR

T1 - Autoprobiotics as an Approach for Restoration of Personalised Microbiota

AU - Суворов, Александр Николаевич

AU - Карасева, Алена Борисовна

AU - Котылева, Марина Петровна

AU - Кондратенко, Юлия Дмитриевна

AU - Лавренова, Надежда

AU - Коробейников, Антон Иванович

AU - Козырев, Петр Александрович

AU - Крамская, Татьяна Анатольевна

AU - Леонтьева, Галина

AU - Кудрявцев, Игорь Владимирович

AU - Guo, Danyang

AU - Лапидус, Алла Львовна

AU - Ермоленко, Елена Игоревна

PY - 2018/9/12

Y1 - 2018/9/12

N2 - Human microbiota is a complex consortium of microorganisms involved in the proper functioning of almost every system of the organism. Majority of the human diseases are associated with the development of intestinal dysbiosis. Dysbiotic condition or dysbiosis is a key pathogenic condition causing many severe infectious or non-infectious diseases. Rapid return to the original microbiota in many cases leads to the fast recovery from the disease. However, the optimal way of the treatment of dysbiosis is still under the discussion. Recently we have developed a method of autoprobiotics based on using isolated indigenous bacteria for improving of microbiota condition. The method based on feeding the patients with bacterial products grown from their personal, genetically characterised strains have been successfully tested in clinic on patients with IBS or chronic pneumonia. In present study we tried to evaluate technology employing autoprobiotic bacteria belonging to different species employing the rat model of antibiotic induced dysbiosis. Six experimental groups of animals after taking antibiotics were treated with different variants of autoprobiotics (lactobacillus, bifidobacteria, enterococcus, their mixture, fecal microbiota, or anaerobically grown complex of indigenous microbiota) prepared for each of them before the development of dysbiosis. Judging by the multiple parameters including metagenomics analysis of microbiota, immune status and microbiota content of the animals with dysbiosis relatively to control group, the most pronounced positive changes were provided by autoprobiotics based on enterococci, bifidobacteria or the consortium of indigenous bacteria grown under anaerobic conditions. These groups of autoprobiotics were delivering the most effective restoration of the original microbiota content and significant anti-inflammatory reaction of the immune system.

AB - Human microbiota is a complex consortium of microorganisms involved in the proper functioning of almost every system of the organism. Majority of the human diseases are associated with the development of intestinal dysbiosis. Dysbiotic condition or dysbiosis is a key pathogenic condition causing many severe infectious or non-infectious diseases. Rapid return to the original microbiota in many cases leads to the fast recovery from the disease. However, the optimal way of the treatment of dysbiosis is still under the discussion. Recently we have developed a method of autoprobiotics based on using isolated indigenous bacteria for improving of microbiota condition. The method based on feeding the patients with bacterial products grown from their personal, genetically characterised strains have been successfully tested in clinic on patients with IBS or chronic pneumonia. In present study we tried to evaluate technology employing autoprobiotic bacteria belonging to different species employing the rat model of antibiotic induced dysbiosis. Six experimental groups of animals after taking antibiotics were treated with different variants of autoprobiotics (lactobacillus, bifidobacteria, enterococcus, their mixture, fecal microbiota, or anaerobically grown complex of indigenous microbiota) prepared for each of them before the development of dysbiosis. Judging by the multiple parameters including metagenomics analysis of microbiota, immune status and microbiota content of the animals with dysbiosis relatively to control group, the most pronounced positive changes were provided by autoprobiotics based on enterococci, bifidobacteria or the consortium of indigenous bacteria grown under anaerobic conditions. These groups of autoprobiotics were delivering the most effective restoration of the original microbiota content and significant anti-inflammatory reaction of the immune system.

KW - Anti-inflammatory

KW - Autoprobiotics

KW - Intestinal dysbiosis

KW - Microbiome

KW - Microbiota

KW - microbiota

KW - anti-inflammatory

KW - PROBIOTICS

KW - intestinal dysbiosis

KW - autoprobiotics

KW - microbiome

UR - http://www.scopus.com/inward/record.url?scp=85055112944&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/autoprobiotics-approach-restoration-personalised-microbiota

U2 - 10.3389/fmicb.2018.01869

DO - 10.3389/fmicb.2018.01869

M3 - Article

C2 - 30258408

VL - 9

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - SEP

M1 - 1869

ER -

ID: 35159809